Bank of Montreal
MNPR icon

Bank of Montreal’s Monopar Therapeutics MNPR Stock Holding History

Bank of Montreal’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,600
Closed -$216K – 4466
2019
Q4 		$216K Buy
+2,600
New +$272K ﹤0.01% 3121

Other funds holding MNPR

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of Montreal's MNPR Position: Q1 2020 in Review

Bank of Montreal sold out of Monopar Therapeutics (MNPR) in Q1 2020, closing a stake of 2,600 shares — an estimated $216K sold.

Bank of Montreal first reported a position in MNPR in Q4 2019 and held it in 1 quarter. The position peaked at $216K in Q4 2019. 7 funds tracked by Wall St. Rank hold MNPR as of Q1 2020.

  • Bank of Montreal reported no remaining Monopar Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 2,600 Monopar Therapeutics shares in Q1 2020, an estimated $216K.
  • Bank of Montreal first reported a position in Monopar Therapeutics in Q4 2019 and held it in 1 quarter.
  • Bank of Montreal's Monopar Therapeutics position peaked at $216K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.